ISSN 2996-8968
Vol. 7, Issue 2, 2016September 26, 2016 EDT
Mitigating the Risks of Generic Drug Product Development: An Application of Quality by Design (QbD) and Question based Review (QbR) Approaches.
Mitigating the Risks of Generic Drug Product Development: An Application of Quality by Design (QbD) and Question based Review (QbR) Approaches.
Articles in Vol. 7, Issue 2, 2016
Vol. 7, Issue 2, 2016
- Maximization of the in vitro transcorneal release and the in vivo IOP-lowering effects of Latanoprost ophthalmic gel formulations using Azone as a penetration enhancer and Carbopol-974® as a mucoadhesive.Mohsen I. AfounaHatem R. RoshdyHany M. IbrahimAshraf B. NaimAdnan El-Marzoqi
- Mitigating the Risks of Generic Drug Product Development: An Application of Quality by Design (QbD) and Question based Review (QbR) Approaches.Manjurul Kader
- Can analytical testing of excipients be ‘volkswagenized’?Shireesh Apte
Kader, Manjurul. 2016. “Mitigating the Risks of Generic Drug Product Development: An Application of Quality by Design (QbD) and Question Based Review (QbR) Approaches.” International Journal of Pharmaceutical Excipients 7 (2). https://doi.org/10.66617/001c.915.